A new British Journal of Clinical Pharmacology study indicates that certain markers can help predict which patients may experience problems after receiving an organ transplant.
The urinary markers, called miR-155-5p and CXCL10, can be measured after transplantation to predict the likelihood of acute rejection and organ dysfunction.
"Large prospective randomised multicentre trials are warranted to refine our cut-off values and validate the clinical usefulness of these biomarkers," wrote the authors of the study.
###
British Journal of Clinical Pharmacology